1. Home
  2. RYTM vs GPK Comparison

RYTM vs GPK Comparison

Compare RYTM & GPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • GPK
  • Stock Information
  • Founded
  • RYTM 2008
  • GPK 2007
  • Country
  • RYTM United States
  • GPK United States
  • Employees
  • RYTM N/A
  • GPK N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • GPK Containers/Packaging
  • Sector
  • RYTM Health Care
  • GPK Consumer Discretionary
  • Exchange
  • RYTM Nasdaq
  • GPK Nasdaq
  • Market Cap
  • RYTM 5.9B
  • GPK 6.4B
  • IPO Year
  • RYTM 2017
  • GPK 1992
  • Fundamental
  • Price
  • RYTM $88.64
  • GPK $23.45
  • Analyst Decision
  • RYTM Strong Buy
  • GPK Buy
  • Analyst Count
  • RYTM 13
  • GPK 8
  • Target Price
  • RYTM $89.77
  • GPK $26.38
  • AVG Volume (30 Days)
  • RYTM 1.0M
  • GPK 3.2M
  • Earning Date
  • RYTM 08-05-2025
  • GPK 07-29-2025
  • Dividend Yield
  • RYTM N/A
  • GPK 1.89%
  • EPS Growth
  • RYTM N/A
  • GPK N/A
  • EPS
  • RYTM N/A
  • GPK 2.05
  • Revenue
  • RYTM $136,863,000.00
  • GPK $8,668,000,000.00
  • Revenue This Year
  • RYTM $37.47
  • GPK N/A
  • Revenue Next Year
  • RYTM $71.16
  • GPK $2.52
  • P/E Ratio
  • RYTM N/A
  • GPK $11.34
  • Revenue Growth
  • RYTM 48.88
  • GPK N/A
  • 52 Week Low
  • RYTM $40.61
  • GPK $20.86
  • 52 Week High
  • RYTM $94.80
  • GPK $30.70
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 71.18
  • GPK 58.91
  • Support Level
  • RYTM $87.86
  • GPK $21.79
  • Resistance Level
  • RYTM $92.14
  • GPK $22.77
  • Average True Range (ATR)
  • RYTM 3.57
  • GPK 0.46
  • MACD
  • RYTM 1.01
  • GPK 0.11
  • Stochastic Oscillator
  • RYTM 77.38
  • GPK 83.97

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.

Share on Social Networks: